andarine developmental code names investigational selective androgen receptor modulator sarm developed gtx inc treatment conditions muscle wasting osteoporosis benign prostatic hypertrophy using nonsteroidal antiandrogen bicalutamide lead andarine orally active partial agonist androgen receptor ar intact male rats mg andarine daily shown reduce prostate weight nonsignificantly increased levator ani muscle weight castrated male rats dose restored prostate weight levator ani muscle weight suggests andarine able competitively block binding dihydrotestosterone receptor targets prostate gland partial agonist actions androgen receptor prevent side effects associated antiandrogens traditionally used treatment antineoplastic immunomodulatory drug article stub help wikipedia expanding drug article relating genitourinary system stub help wikipedia expanding httpsenwikipediaorgwikiandarine